Eurohlth Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUROHLTH INTL, and what generic and branded alternatives to EUROHLTH INTL drugs are available?
EUROHLTH INTL has three approved drugs.
There is one tentative approval on EUROHLTH INTL drugs.
Summary for Eurohlth Intl
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Eurohlth Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eurohlth Intl Sarl | ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE | acyclovir sodium | INJECTABLE;INJECTION | 074885-002 | Dec 19, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Eurohlth Intl Sarl | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074913-002 | Oct 15, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Eurohlth Intl Sarl | AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 209337-001 | Jun 8, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eurohlth Intl Sarl | ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE | acyclovir sodium | INJECTABLE;INJECTION | 074885-001 | Dec 19, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Eurohlth Intl Sarl | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074913-001 | Oct 15, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
